Opioid use disorder in pregnancy: leveraging provider perceptions to inform comprehensive treatment
JournalBMC Health Services Research
MetadataShow full item record
AbstractBackground: Medications for opioid use disorder (MOUD) are recommended with adjuvant behavioral therapies, counseling, and other services for comprehensive treatment of maternal opioid use disorder. Inadequate access to treatment, lack of prescribing providers and complex delivery models are among known barriers to care. Multi-disciplinary provider input can be leveraged to comprehend factors that facilitate or inhibit treatment. The objective of this study is to explore provider perceptions of MOUD and factors critical to comprehensive treatment delivery to improve the care of pregnant women with opioid use disorder. Methods: A qualitative research approach was used to gather data from individual provider and group semi-structured interviews. Providers (n = 12) responded to questions in several domains related to perceptions of MOUD, treatment delivery, access to resources, and challenges/barriers. Data were collected, transcribed, coded (by consensus) and emerging themes were analyzed using grounded theory methodology. Results: Emerging themes revealed persistent gaps in treatment and challenges in provider, health systems and patient factors. Providers perceived MOUD to be a "lifeline" to women. Conclusions: Inconsistencies in treatment provision, access and uptake can be improved by leveraging provider perceptions, direct experiences and recommendations for an integrated team-based, patient-centered approach to guide the care of pregnant women with opioid use disorder. Copyright 2021, The Author(s).
SponsorsThis study was supported by the Parent Project Grant #10020715, Patient-Centered Involvement in Evaluating the Effectiveness of Treatments (PATIENT) and Patient-Centered Outcomes Research (PCOR) projects.
KeywordMedications for opioid use disorder
Opioid use disorder
Pregnancy and healthcare provider
Qualitative pilot study
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/15169
- Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
- Authors: Sufrin C, Sutherland L, Beal L, Terplan M, Latkin C, Clarke JG
- Issue date: 2020 Nov
- Medications for opioid use disorder in pregnancy in a state women's prison facility.
- Authors: Knittel AK, Zarnick S, Thorp JM Jr, Amos E, Jones HE
- Issue date: 2020 Sep 1
- Provision and uptake of routine antenatal services: a qualitative evidence synthesis.
- Authors: Downe S, Finlayson K, Tunçalp Ö, Gülmezoglu AM
- Issue date: 2019 Jun 12
- Provider-directed marketing may increase prescribing of medications for opioid use disorder.
- Authors: Nguyen T, Andraka-Christou B, Simon K, Bradford WD
- Issue date: 2019 Sep
- Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states.
- Authors: Patrick SW, Buntin MB, Martin PR, Scott TA, Dupont W, Richards M, Cooper WO
- Issue date: 2019